A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1
Clinical trial NCT05406583 · COMPLETED
Trial details
- NCT number
- NCT05406583
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-05
- Primary completion
- 2025-03-12
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.